Cargando…
The new 6q27 tumor suppressor DACT2, frequently silenced by CpG methylation, sensitizes nasopharyngeal cancer cells to paclitaxel and 5-FU toxicity via β-catenin/Cdc25c signaling and G2/M arrest
BACKGROUND: Nasopharyngeal carcinoma (NPC) is prevalent in South China, including Hong Kong and Southeast Asia, constantly associated with Epstein-Barr virus (EBV) infection. Epigenetic etiology attributed to EBV plays a critical role in NPC pathogenesis. Through previous CpG methylome study, we ide...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136178/ https://www.ncbi.nlm.nih.gov/pubmed/30359298 http://dx.doi.org/10.1186/s13148-018-0459-2 |
_version_ | 1783354947427893248 |
---|---|
author | Zhang, Yan Fan, Jiangxia Fan, Yichao Li, Lili He, Xiaoqian Xiang, Qin Mu, Junhao Zhou, Danfeng Sun, Xuejuan Yang, Yucheng Ren, Guosheng Tao, Qian Xiang, Tingxiu |
author_facet | Zhang, Yan Fan, Jiangxia Fan, Yichao Li, Lili He, Xiaoqian Xiang, Qin Mu, Junhao Zhou, Danfeng Sun, Xuejuan Yang, Yucheng Ren, Guosheng Tao, Qian Xiang, Tingxiu |
author_sort | Zhang, Yan |
collection | PubMed |
description | BACKGROUND: Nasopharyngeal carcinoma (NPC) is prevalent in South China, including Hong Kong and Southeast Asia, constantly associated with Epstein-Barr virus (EBV) infection. Epigenetic etiology attributed to EBV plays a critical role in NPC pathogenesis. Through previous CpG methylome study, we identified Disheveled-associated binding antagonist of beta-catenin 2 (DACT2) as a methylated target in NPC. Although DACT2 was shown to regulate Wnt signaling in some carcinomas, its functions in NPC pathogenesis remain unclear. METHODS: RT-PCR, qPCR, MSP, and BGS were applied to measure expression levels and promoter methylation of DACT2 in NPC. Transwell, flow cytometric analysis, colony formation, and BrdU-ELISA assay were used to assess different biological functions affected by DACT2. Immunofluorescence, Western blot, and dual-luciferase reporter assay were used to explore the mechanisms of DACT2 functions. Chemosensitivity assay was used to measure the impact of DACT2 on chemotherapy drugs. RESULTS: We found that DACT2 is readily expressed in multiple normal adult tissues including upper respiratory tissues. However, it is frequently downregulated in NPC and correlated with promoter methylation. DNA methyltransferase inhibitor 5-aza-2′-deoxycytidine restored its expression in NPC cells. DACT2 methylation was further detected in 29/32 (91%) NPC tumors but not in any (0/8) normal nasopharyngeal tissue samples. Ectopic expression of DACT2 in NPC cells suppressed their proliferation, migration, and invasion through downregulating matrix metalloproteinases. DACT2 expression also induced G2/M arrest in NPC cells through directly suppressing β-catenin/Cdc25c signaling, which sensitized NPC cells to paclitaxel and 5-FU, but not cisplatin. CONCLUSION: Our results demonstrate that DACT2 is frequently inactivated epigenetically by CpG methylation in NPC, while it inhibits NPC cell proliferation and metastasis via suppressing β-catenin/Cdc25c signaling. Our study suggests that DACT2 promoter methylation is a potential epigenetic biomarker for the detection and chemotherapy guidance of NPC. |
format | Online Article Text |
id | pubmed-6136178 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-61361782018-09-15 The new 6q27 tumor suppressor DACT2, frequently silenced by CpG methylation, sensitizes nasopharyngeal cancer cells to paclitaxel and 5-FU toxicity via β-catenin/Cdc25c signaling and G2/M arrest Zhang, Yan Fan, Jiangxia Fan, Yichao Li, Lili He, Xiaoqian Xiang, Qin Mu, Junhao Zhou, Danfeng Sun, Xuejuan Yang, Yucheng Ren, Guosheng Tao, Qian Xiang, Tingxiu Clin Epigenetics Research BACKGROUND: Nasopharyngeal carcinoma (NPC) is prevalent in South China, including Hong Kong and Southeast Asia, constantly associated with Epstein-Barr virus (EBV) infection. Epigenetic etiology attributed to EBV plays a critical role in NPC pathogenesis. Through previous CpG methylome study, we identified Disheveled-associated binding antagonist of beta-catenin 2 (DACT2) as a methylated target in NPC. Although DACT2 was shown to regulate Wnt signaling in some carcinomas, its functions in NPC pathogenesis remain unclear. METHODS: RT-PCR, qPCR, MSP, and BGS were applied to measure expression levels and promoter methylation of DACT2 in NPC. Transwell, flow cytometric analysis, colony formation, and BrdU-ELISA assay were used to assess different biological functions affected by DACT2. Immunofluorescence, Western blot, and dual-luciferase reporter assay were used to explore the mechanisms of DACT2 functions. Chemosensitivity assay was used to measure the impact of DACT2 on chemotherapy drugs. RESULTS: We found that DACT2 is readily expressed in multiple normal adult tissues including upper respiratory tissues. However, it is frequently downregulated in NPC and correlated with promoter methylation. DNA methyltransferase inhibitor 5-aza-2′-deoxycytidine restored its expression in NPC cells. DACT2 methylation was further detected in 29/32 (91%) NPC tumors but not in any (0/8) normal nasopharyngeal tissue samples. Ectopic expression of DACT2 in NPC cells suppressed their proliferation, migration, and invasion through downregulating matrix metalloproteinases. DACT2 expression also induced G2/M arrest in NPC cells through directly suppressing β-catenin/Cdc25c signaling, which sensitized NPC cells to paclitaxel and 5-FU, but not cisplatin. CONCLUSION: Our results demonstrate that DACT2 is frequently inactivated epigenetically by CpG methylation in NPC, while it inhibits NPC cell proliferation and metastasis via suppressing β-catenin/Cdc25c signaling. Our study suggests that DACT2 promoter methylation is a potential epigenetic biomarker for the detection and chemotherapy guidance of NPC. BioMed Central 2018-02-27 /pmc/articles/PMC6136178/ /pubmed/30359298 http://dx.doi.org/10.1186/s13148-018-0459-2 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Zhang, Yan Fan, Jiangxia Fan, Yichao Li, Lili He, Xiaoqian Xiang, Qin Mu, Junhao Zhou, Danfeng Sun, Xuejuan Yang, Yucheng Ren, Guosheng Tao, Qian Xiang, Tingxiu The new 6q27 tumor suppressor DACT2, frequently silenced by CpG methylation, sensitizes nasopharyngeal cancer cells to paclitaxel and 5-FU toxicity via β-catenin/Cdc25c signaling and G2/M arrest |
title | The new 6q27 tumor suppressor DACT2, frequently silenced by CpG methylation, sensitizes nasopharyngeal cancer cells to paclitaxel and 5-FU toxicity via β-catenin/Cdc25c signaling and G2/M arrest |
title_full | The new 6q27 tumor suppressor DACT2, frequently silenced by CpG methylation, sensitizes nasopharyngeal cancer cells to paclitaxel and 5-FU toxicity via β-catenin/Cdc25c signaling and G2/M arrest |
title_fullStr | The new 6q27 tumor suppressor DACT2, frequently silenced by CpG methylation, sensitizes nasopharyngeal cancer cells to paclitaxel and 5-FU toxicity via β-catenin/Cdc25c signaling and G2/M arrest |
title_full_unstemmed | The new 6q27 tumor suppressor DACT2, frequently silenced by CpG methylation, sensitizes nasopharyngeal cancer cells to paclitaxel and 5-FU toxicity via β-catenin/Cdc25c signaling and G2/M arrest |
title_short | The new 6q27 tumor suppressor DACT2, frequently silenced by CpG methylation, sensitizes nasopharyngeal cancer cells to paclitaxel and 5-FU toxicity via β-catenin/Cdc25c signaling and G2/M arrest |
title_sort | new 6q27 tumor suppressor dact2, frequently silenced by cpg methylation, sensitizes nasopharyngeal cancer cells to paclitaxel and 5-fu toxicity via β-catenin/cdc25c signaling and g2/m arrest |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136178/ https://www.ncbi.nlm.nih.gov/pubmed/30359298 http://dx.doi.org/10.1186/s13148-018-0459-2 |
work_keys_str_mv | AT zhangyan thenew6q27tumorsuppressordact2frequentlysilencedbycpgmethylationsensitizesnasopharyngealcancercellstopaclitaxeland5futoxicityviabcatenincdc25csignalingandg2marrest AT fanjiangxia thenew6q27tumorsuppressordact2frequentlysilencedbycpgmethylationsensitizesnasopharyngealcancercellstopaclitaxeland5futoxicityviabcatenincdc25csignalingandg2marrest AT fanyichao thenew6q27tumorsuppressordact2frequentlysilencedbycpgmethylationsensitizesnasopharyngealcancercellstopaclitaxeland5futoxicityviabcatenincdc25csignalingandg2marrest AT lilili thenew6q27tumorsuppressordact2frequentlysilencedbycpgmethylationsensitizesnasopharyngealcancercellstopaclitaxeland5futoxicityviabcatenincdc25csignalingandg2marrest AT hexiaoqian thenew6q27tumorsuppressordact2frequentlysilencedbycpgmethylationsensitizesnasopharyngealcancercellstopaclitaxeland5futoxicityviabcatenincdc25csignalingandg2marrest AT xiangqin thenew6q27tumorsuppressordact2frequentlysilencedbycpgmethylationsensitizesnasopharyngealcancercellstopaclitaxeland5futoxicityviabcatenincdc25csignalingandg2marrest AT mujunhao thenew6q27tumorsuppressordact2frequentlysilencedbycpgmethylationsensitizesnasopharyngealcancercellstopaclitaxeland5futoxicityviabcatenincdc25csignalingandg2marrest AT zhoudanfeng thenew6q27tumorsuppressordact2frequentlysilencedbycpgmethylationsensitizesnasopharyngealcancercellstopaclitaxeland5futoxicityviabcatenincdc25csignalingandg2marrest AT sunxuejuan thenew6q27tumorsuppressordact2frequentlysilencedbycpgmethylationsensitizesnasopharyngealcancercellstopaclitaxeland5futoxicityviabcatenincdc25csignalingandg2marrest AT yangyucheng thenew6q27tumorsuppressordact2frequentlysilencedbycpgmethylationsensitizesnasopharyngealcancercellstopaclitaxeland5futoxicityviabcatenincdc25csignalingandg2marrest AT renguosheng thenew6q27tumorsuppressordact2frequentlysilencedbycpgmethylationsensitizesnasopharyngealcancercellstopaclitaxeland5futoxicityviabcatenincdc25csignalingandg2marrest AT taoqian thenew6q27tumorsuppressordact2frequentlysilencedbycpgmethylationsensitizesnasopharyngealcancercellstopaclitaxeland5futoxicityviabcatenincdc25csignalingandg2marrest AT xiangtingxiu thenew6q27tumorsuppressordact2frequentlysilencedbycpgmethylationsensitizesnasopharyngealcancercellstopaclitaxeland5futoxicityviabcatenincdc25csignalingandg2marrest AT zhangyan new6q27tumorsuppressordact2frequentlysilencedbycpgmethylationsensitizesnasopharyngealcancercellstopaclitaxeland5futoxicityviabcatenincdc25csignalingandg2marrest AT fanjiangxia new6q27tumorsuppressordact2frequentlysilencedbycpgmethylationsensitizesnasopharyngealcancercellstopaclitaxeland5futoxicityviabcatenincdc25csignalingandg2marrest AT fanyichao new6q27tumorsuppressordact2frequentlysilencedbycpgmethylationsensitizesnasopharyngealcancercellstopaclitaxeland5futoxicityviabcatenincdc25csignalingandg2marrest AT lilili new6q27tumorsuppressordact2frequentlysilencedbycpgmethylationsensitizesnasopharyngealcancercellstopaclitaxeland5futoxicityviabcatenincdc25csignalingandg2marrest AT hexiaoqian new6q27tumorsuppressordact2frequentlysilencedbycpgmethylationsensitizesnasopharyngealcancercellstopaclitaxeland5futoxicityviabcatenincdc25csignalingandg2marrest AT xiangqin new6q27tumorsuppressordact2frequentlysilencedbycpgmethylationsensitizesnasopharyngealcancercellstopaclitaxeland5futoxicityviabcatenincdc25csignalingandg2marrest AT mujunhao new6q27tumorsuppressordact2frequentlysilencedbycpgmethylationsensitizesnasopharyngealcancercellstopaclitaxeland5futoxicityviabcatenincdc25csignalingandg2marrest AT zhoudanfeng new6q27tumorsuppressordact2frequentlysilencedbycpgmethylationsensitizesnasopharyngealcancercellstopaclitaxeland5futoxicityviabcatenincdc25csignalingandg2marrest AT sunxuejuan new6q27tumorsuppressordact2frequentlysilencedbycpgmethylationsensitizesnasopharyngealcancercellstopaclitaxeland5futoxicityviabcatenincdc25csignalingandg2marrest AT yangyucheng new6q27tumorsuppressordact2frequentlysilencedbycpgmethylationsensitizesnasopharyngealcancercellstopaclitaxeland5futoxicityviabcatenincdc25csignalingandg2marrest AT renguosheng new6q27tumorsuppressordact2frequentlysilencedbycpgmethylationsensitizesnasopharyngealcancercellstopaclitaxeland5futoxicityviabcatenincdc25csignalingandg2marrest AT taoqian new6q27tumorsuppressordact2frequentlysilencedbycpgmethylationsensitizesnasopharyngealcancercellstopaclitaxeland5futoxicityviabcatenincdc25csignalingandg2marrest AT xiangtingxiu new6q27tumorsuppressordact2frequentlysilencedbycpgmethylationsensitizesnasopharyngealcancercellstopaclitaxeland5futoxicityviabcatenincdc25csignalingandg2marrest |